Lost Tolerance: The Risk of Returning to Drug Use

Drug tolerance can fall after abstinence. Learn why returning to drug use can increase overdose risks and how harm reduction can help.
Lost Tolerance: The Hidden Risk of Returning to Drug Use
There is a risk associated with returning to drug use after a period of abstinence that does not always receive enough attention: the body may no longer tolerate what it once did.
Someone who used a substance regularly for years may believe they understand their limits. They may remember what they previously took, how it affected them and what they could handle without experiencing serious problems.
But the body changes. Tolerance can decrease when substance use stops or is significantly reduced. If someone later returns to their previous patterns of use, they may expose themselves to risks they no longer fully appreciate.
For some substances, this can mean an unpleasant or overwhelming experience. With opioids, it can mean a potentially fatal overdose.
This is not simply a medical detail. It is an important harm-reduction issue, particularly for people returning to use after rehabilitation, detoxification, incarceration, hospitalisation or a prolonged period away from substances.
What is drug tolerance?
Tolerance develops when the body adapts to repeated exposure to a substance.
Over time, the same amount may produce a weaker effect than it previously did. A person may find that they need more of a substance to experience effects they once experienced with less.
Tolerance is not identical for every drug. It can involve different biological processes, and it may develop differently depending on the substance, frequency of exposure, individual physiology and other circumstances.
It is also important to distinguish tolerance from dependence and addiction. They are related concepts, but they are not interchangeable.
- Tolerance means the body has adapted and responds differently to a substance.
- Physical dependence means the body has adapted to the presence of a substance, potentially producing withdrawal symptoms when it is reduced or stopped.
- Substance use disorder involves a pattern of use associated with impaired control, continued use despite harm and other significant consequences.
A person can develop tolerance without necessarily having a substance use disorder. Equally, someone can experience a substance use disorder without developing the same degree of tolerance as another person.
Understanding these differences matters because they influence how people experience periods of reduced or discontinued use.
What happens when tolerance decreases?
When repeated exposure to a substance stops, the adaptations that developed during regular use can gradually change.
The body may become more sensitive to the substance again. However, this process does not necessarily happen at the same rate for everyone, and there is no universal timeline that applies across all drugs.
The important point is that a person’s previous tolerance should never be assumed to remain unchanged.
This creates a potentially dangerous situation when someone returns to use and relies on their past experience to judge what their body can handle.
They may remember what they previously tolerated, but that experience may no longer reflect their current physiological response.
The risk is particularly serious with opioids, where reduced tolerance can make a previously familiar amount capable of causing respiratory depression and overdose.
Why returning to opioid use can be particularly dangerous
Opioids, including heroin, morphine, oxycodone and fentanyl, can suppress the central nervous system and slow breathing.
With repeated exposure, a person may develop tolerance to some of these effects. Following a period without opioids, that tolerance can decrease.
If opioid use resumes at a level that the person previously tolerated, the body may no longer be able to handle the same exposure.
This is one reason overdose risk increases after periods of abstinence.
The World Health Organization specifically identifies resuming opioid use after an extended period of abstinence as an overdose risk factor. It highlights periods following detoxification, release from incarceration and cessation of treatment as particularly important situations.
The European Union Drugs Agency also identifies reduced tolerance after detoxification or drug-free treatment as a significant risk when people resume opioid use.
This is not limited to people who have been away from substances for years. A period of reduced or interrupted use can change a person’s tolerance, although the extent and timing vary.
There is no reliable personal calculation that can establish when tolerance has fallen or what amount would be safe.
The danger after rehabilitation, detoxification and prison
Some of the most vulnerable periods occur when people leave environments where access to substances has been interrupted.
Consider someone who has used opioids regularly for several years before entering rehabilitation or serving a prison sentence.
During that period, their tolerance may decrease considerably. When they return to their previous environment, they may encounter familiar people, places and circumstances.
They may also experience stress, uncertainty, isolation or pressure to return to old routines.
The danger is that their expectations may not have changed alongside their tolerance.
They might believe they can return to the same patterns they followed before leaving. Their body, however, may respond very differently.
Research and public health guidance have repeatedly identified the period immediately following release from prison or discharge from drug-free treatment as a time of increased overdose risk.
The WHO identifies the first four weeks following release from prison as a particularly important period for people with opioid dependence.
This is why continuity of care matters. Leaving treatment or incarceration should not mean leaving behind access to medical support, overdose prevention and other services.
It is not just about returning after years away
A common misunderstanding is that reduced tolerance only affects people who have been abstinent for a very long time.
That is not a safe assumption.
Changes in tolerance can occur following interruptions in regular use, but the speed and extent depend on the substance and the individual.
Someone who has been hospitalised, experienced illness, stopped using during a period of personal difficulty or significantly reduced their consumption may find that their previous tolerance has changed.
There are also people who use substances intermittently rather than every day. They may never develop the same level of tolerance as someone with frequent exposure.
The important message is not to calculate how much tolerance someone may have lost. It is to recognise that previous experience cannot reliably predict present-day safety.
The unpredictable drug supply makes the risk worse
Reduced tolerance is already a serious concern. An unpredictable drug supply adds another layer of danger.
People purchasing substances from unregulated sources may have no reliable way of knowing their actual contents, strength or consistency.
A substance that appears similar to something previously used may contain different ingredients or a much more potent substance.
This is particularly concerning with opioids, including illicitly manufactured fentanyl and other potent synthetic opioids.
The combination of reduced tolerance and an unpredictable supply can make the outcome difficult to anticipate.
Even someone who believes they are returning to a familiar substance may be exposed to something substantially different.
This is one reason drug checking services, where available, can play an important role in harm reduction. They can provide information about substances, although no testing method can guarantee that a sample is completely safe or identify every possible risk.
Practical harm reduction: reducing the risks of returning to use
Harm reduction does not require people to make promises about permanent abstinence. It starts with acknowledging that people may return to substance use and making sure they have access to information and support that can reduce preventable harm.
For anyone who has experienced a period of abstinence or significantly reduced use, several precautions are particularly important.
Do not assume your previous tolerance is still there
This is the central message.
What someone previously tolerated is not a reliable indication of what their body can handle now.
There is no dependable way to calculate lost tolerance from memory, past experience or the length of time someone has been abstinent.
Make naloxone available where opioid exposure is possible
Naloxone is a medication that can temporarily reverse an opioid overdose.
It can restore breathing in someone experiencing an opioid overdose and can be lifesaving when administered promptly.
People who use opioids, their friends, family members and others who may witness an overdose should know how to access and use naloxone.
It is important to understand that naloxone only reverses opioid effects. It does not reverse an overdose caused solely by stimulants, alcohol or other non-opioid substances.
Emergency medical assistance is still essential, even if naloxone appears to work.
Avoid using alone
An overdose or other serious medical emergency can become fatal when nobody is present to recognise what is happening or call for help.
Having a trusted person available who is not using at the same time can make a significant difference.
That person should know the warning signs of an overdose, how to respond and how to contact emergency services.
Where in-person support is unavailable, services offering remote overdose monitoring or supervised support may provide another option, depending on local availability.
Be aware of dangerous combinations
Combining opioids with alcohol, benzodiazepines or other substances that suppress the central nervous system can significantly increase the risk of respiratory depression and overdose.
A person returning to use may underestimate these interactions, particularly if their tolerance has changed.
Prescription medicines also matter. Medical professionals should be informed about relevant substance use when assessing medication risks.
Stay connected to treatment and support
For people with opioid dependence, evidence-based treatment can reduce overdose risk.
Methadone and buprenorphine are established treatment options. They can help manage opioid dependence and reduce the risks associated with returning to uncontrolled opioid use.
Detoxification alone does not provide the same protection as ongoing treatment and support.
People leaving rehabilitation, hospital care or incarceration should ideally have continuity of care arranged rather than being left to navigate the transition alone.
Know the signs of an opioid overdose
An opioid overdose can involve:
- Very slow, shallow or absent breathing.
- Inability to wake the person.
- Unusual gurgling or choking sounds.
- Blue, grey or unusually pale lips and fingertips.
- Pinpoint pupils, although this sign is not always present.
If an overdose is suspected, call emergency services immediately. Administer naloxone if available, follow the emergency operator’s instructions and provide rescue breathing or CPR if trained and appropriate. Stay with the person until help arrives.
Do not assume someone can simply sleep off a suspected overdose.
Friends and family have an important role
People returning to substance use can face considerable pressure, especially after a period of treatment or abstinence.
They may feel embarrassed about returning to use, fear judgement or avoid asking for help because they believe others will see it as a failure.
This can create isolation at precisely the time when support is most important.
Friends and family members can help by understanding that tolerance changes and that a person’s previous experience does not guarantee their present safety.
Having naloxone available, learning to recognise overdose symptoms and knowing how to contact emergency services are practical steps that can save lives.
Just as importantly, conversations should remain open and non-judgmental.
Shame does not reverse an overdose. Punishment does not restore tolerance. Support, access to healthcare and accurate information can make a meaningful difference.
Returning to use is not a moral failure
There is another part of this subject that deserves attention.
Public discussions about addiction and relapse can sometimes become dominated by judgement. People who return to substance use may be described as having failed, wasted an opportunity or thrown away their progress.
That language does very little to address the actual risks.
A return to use can happen for many reasons, including dependence, mental health difficulties, social circumstances, trauma, disrupted treatment and a lack of support.
It should be treated as a situation that deserves care and an appropriate response, not as an opportunity to shame someone.
Most importantly, a return to use can be dangerous even when someone genuinely intends to avoid the patterns that caused problems in the past.
Understanding reduced tolerance is one way of recognising that risk before it becomes an emergency.
The experience you remember may no longer reflect the risk
One of the most dangerous assumptions a person can make after a period away from substances is that their body will respond exactly as it did before.
It may not.
Tolerance changes. Physical circumstances change. Health changes. The substances available may also be different from what someone remembers.
For opioids in particular, returning to previous patterns after abstinence can carry a serious risk of fatal overdose.
This is why harm-reduction information must reach people before they return to use, not only after an overdose has occurred.
People deserve access to accurate information without judgement, regardless of whether they are currently using, trying to stop, receiving treatment or considering returning to use.
Harm reduction is not about judging someone’s decisions. It is about recognising risks, sharing knowledge and preventing deaths that might otherwise be avoidable.



